October 31, 2024
Estrogen exerts neuroprotective effects on the brain, and the reduction in endogenous estrogen after menopause increases women’s risk for Alzheimer’s disease (AD), cerebrovascular disease, or both. […]
October 30, 2024
TOPLINE: Poor sleep quality in early middle age is associated with signs of accelerated brain aging in late middle age, a new study shows. Investigators say […]
October 30, 2024
Abu Dhabi, UAE — In the latest multicenter randomized trial testing a combination of edaravone and dexborneol for the treatment of acute stroke, the proportion of […]
October 30, 2024
ABU DHABI, UAE — Thrombolysis to treat central retinal artery occlusion, also known as “eye stroke,” appeared to improve visual acuity compared with oral aspirin but […]
October 30, 2024
TOPLINE: Hearing loss is associated with a 26% higher risk for Parkinson’s disease (PD), although hearing aids helped mitigate the risk, a new study shows. METHODOLOGY: […]
October 30, 2024
ABU DHABI, UAE — Thrombolytic treatment with recombinant human pro-urokinase was non-inferior to alteplase in achieving an excellent functional outcome in acute ischemic stroke but showed […]
October 29, 2024
ABU DHABI, UAE — Extending the simple CT angiography (CTA) scan given to all patients with acute stroke on presentation to the hospital to include the […]
October 29, 2024
Abu Dhabi, UAE — New evidence supports the use of direct oral anticoagulants (DOACs) in the treatment of cerebral venous thrombosis (CVT) based on findings from […]
October 29, 2024
ABU DHABI, UAE — One day after two new datasets seemed to remove any doubt that essentially all patients with atrial fibrillation (AF) should receive a […]